High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor

Circulation Research

Volumn 74, Issue 6, 1994, Pages 1149-1156

  Murugesan, Gurunathan ^a   Sa, Gaurisankar ^a   Fox, Paul L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

basic fibroblast growth factor; cell motility; endothelial cells; high density lipoprotein; wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL INJURY; CATTLE; CELL MIGRATION; CELL MOTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ENDOTHELIUM CELL; LIPID ANALYSIS; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; WOUND HEALING;

EID: 0028234578     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.74.6.1149     Document Type: Article

References (55)

1. Ausprunk DH, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res, 1977;14:53-65.
2. Wall RT, Harker LA, Striker GE. Human endothelial cell migration: stimulation by a released platelet factor. Lab Invest. 1978;39:523-529.
3. Schwartz SM, Gajdusek CM, Seiden SC. Vascular wall growth control: the role of the endothelium. Arteriosclerosis. 1981;1: 107-126.
4. Coomber BL, Gotlieb AI. In vitro endothelial wound repair: interaction of cell migration and proliferation. Arteriosclerosis. 1990;10: 215-222.
5. Dulbecco R, Stoker MG. Conditions determining initiation of DNA synthesis in 3T3 cells. Proc Natl Acad Sci U S A. 1970;66: 204-210.
6. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest. 1989;84:1470-1478.
7. Rosen EM, Carley W, Goldberg ID. Scatter factor regulates vascular endothelial cell motility. Cancer Invest. 1990;8:647-650.
8. Terranova VP, DiFloria R, Lyall RM, Hic S, Friesel R, Maciag T. Human endothelial cells are chemotactic to endothelial cell growth factor and heparin. J Cell Biol. 1985;101:2330-2334.
9. Sato Y, Rifkin DB. Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol. 1988;107: 1199-1205.
10. Lindner V, Majack RA, Reidy MA. Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest. 1990;85:2004-2008.
11. Bjornsson TD, Dryjski M, Tluczek J, Mennie R, Ronan J, Mellin TN, Thomas KA. Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A. 1991;88:8651-8655.
12. Lee PL, Johnson DE, Cousens LS, Fried VA, Williams LT. Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science. 1989;245:57-60.
13. Montesano R. Regulation of angiogenesis in vitro. Eur J Clin Invest. 1992;22:504-515.
14. Bürk RR, Clopath P, Müller K. Deficiency in the ability of serum from pigs on an atherogenic diet to stimulate the migration of 3T3 cells in culture. Artery. 1979;6:205-219.
15. Thorgeirsson G, Robertson AL, Cowan DH. Migration of human vascular endothelial and smooth muscle cells. Lab Invest. 1979;41: 51-62.
16. Gotlieb AI, Spector W, Desai K, Steiner G. The effect of low density lipoprotein on in vitro porcine endothelial cell reendothelialization. Artery. 1983;12:132-144.
17. Tauber JP, Goldminz D, Gospodarowicz D. Up-regulation in vascular endothelial cells of binding sites of high density lipoprotein induced by 25-hydroxycholesterol. Eur J Biochem. 1981; 119:327-339.
18. Tauber JP, Cheng J, Gospodarowicz D. Effect of high and low density lipoproteins on proliferation of cultured bovine vascular endothelial cells. J Clin Invest. 1980;66:696-708.
19. Libby P, Miao P, Ordovas JM, Schaefer EJ. Lipoproteins increase growth of mitogen-stimulated arterial smooth muscle cells. J Cell Physiol. 1985;124:1-8.
20. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. JAMA. 1986;256: 2835-2838.
21. Fox PL, DiCorleto PE. Regulation of production of a platelet-derived growth factor-like protein by cultured bovine aortic endothelial cells. J Cell Physiol. 1984;121:298-308.
22. cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol. 1991; 11:1185-1194.
23. Murugesan G, Chisolm GM, Fox PL. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro. J Cell Biol. 1993;120:1011-1019.
24. Hessler JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 1983; 3:215-222.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193: 265-275.
26. Schuh J, Fairclough GF, Haschemeyer RH. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci U S A. 1978;75:3173-3177.
27. Hasselaar P, Sage EH. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. J Cell Biochem. 1992;49:272-283.
28. Baird A, Böhlen P. Fibroblast growth factors. In: Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors I. New York, NY: Springer-Verlag; 1991:369-418.
29. Ui M, Katada T. Bacterial toxins as probe for receptor-Gi coupling. Adv Second Messenger Phosphoprotein Res. 1990;24:63-69.
30. 2 activity. J Biol Chem. 1994;269: 3219-3225.
31. 2 activity and arachidonate metabolism of human neutrophils. Biochim Biophys Acta. 1989; 1001:1-8.
32. Banga HS, Simons ER, Brass LF, Rittenhouse SE. Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine. Proc Natl Acad Sci U S A. 1986;83:9197-9201.
33. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, Fogelman AM. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991;88: 2039-2046.
34. Naito M, Hayashi T, Funaki C, Kuzuya M, Asai K, Kuzuya F. Chemotactic response of vascular smooth muscle cells to acetoacetylated low-density lipoprotein. Heart Vessels. 1988;4: 100-103.
35. Autio I, Jaakkola O, Solakivi T, Nikkari T. Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture. FEBS Lett. 1990;277:247-249.
36. Lipton A, Klinger I, Paul D, Holley RW. Migration of mouse 3T3 fibroblasts in response to a serum factor. Proc Natl Acad Sci U S A. 1971;68:2799-2801.
37. Sholley MM, Gimbrone MA, Cotran RS. Cellular migration and replication in endothelial regeneration: a study using irradiated endothelial cultures. Lab Invest. 1977;36:18-25.
38. Selden SC, Rabinovitch PS, Schwartz SM. Effects of cytoskeletal agents on replication of bovine endothelium. J Cell Physiol. 1981; 108:195-211.
39. Casscells W. Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation. 1992;86:723-729.
40. McKnight GL, Reasoner J, Gilbert T, Sundquist KO, Hokland B, McKernan PA, Champagne J, Johnson CJ, Bailey MC, Holly R, O'Hara PJ, Oram JF. Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. J Biol Chem. 1992;267:12131-12141.
41. Vadiveloo PK, Fidge NH. The role of apoproteins AI and AII in binding of high-density lipoprotein, to membranes derived from bovine aortic endothelial cells. Biochem J. 1992;284:145-151.
42. 3 with endothelial cells, smooth muscle cells, and fibroblasts: evidence against the role of specific ligand and receptor proteins. J Biol Chem. 1984;259:13897-13905.
43. Schmitz G, Lackner KJ. High-density lipoproteins and atherosclerosis. Curr Opin Lipidol. 1993;4:392-400.
44. Subers EM, Nathanson NM. Regulation by high density lipoproteins of muscarinic acetylcholine receptor function in chick heart cells cultured in defined medium. J Biol Chem. 1989;264: 19685-19693.
45. Nazih H, Devred D, Martin-Nizard F, Clavey V, Fruchart JC, Delbart C. Pertussis toxin sensitive G-protein coupling of HDL receptor to phospholipase C in human platelets. Thromb Res. 1992;67:559-567.
46. Fafeur V, Ping Jiang Z, Böhlen P. Signal transduction by bFGF, but not TGFβ1, involves arachidonic acid metabolism in endothelial cells. J Cell Physiol. 1991;149:277-283.
47. 2+ in HL60 granulocytes. J Biol Chem. 1992;267:25966-25975.
48. Darbon JM, Tournier JF, Tauber JP, Bayard F. Possible role of protein phosphorylation in the mitogenic effect of high density lipoproteins on cultured vascular endothelial cells. J Biol Chem. 1986;261:8002-8008.
49. 2+ in cultured fibroblasts. Biochem J. 1991;279:29-33.
50. Voyno-Yasenetskaya TA, Dobbs LG, Erickson SK, Hamilton RL. Low density lipoprotein- and high density lipoprotein-mediated signal transduction and exocytosis in alveolar type II cells. Proc Natl Acad Sci U S A. 1993;90:4256-4260.
51. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991;353:265-267.
52. Badimon JJ, Fuster V, Badimon L. Role of high density lipoproteins in the regression of atherosclerosis. Circulation. 1992; 86(suppl III):III-86-III-94.
53. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990;1044:275-283.
54. Hessler JR, Robertson AL, Chisolm GM. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis. 1979;32: 213-229.
55. Haudenschild CC, Schwartz SM. Endothelial regeneration, II: restitution of endothelial continuity. Lab Invest. 1979;41:407-418.